---
figid: PMC2947383__nihms233283f3
figtitle: 'Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science'
organisms:
- Escherichia coli
- Staphylococcus aureus
- Listeria monocytogenes
- Salmonella enterica
- Vibrio cholerae
- Clostridioides difficile
- Lactiplantibacillus plantarum
- Bacillus cereus
- Lacticaseibacillus casei
- Limosilactobacillus reuteri
- Lactobacillus acidophilus
- Escherichia coli O157H7
- Lacticaseibacillus rhamnosus
- Lacticaseibacillus rhamnosus GG
- Streptococcus thermophilus
- Lactobacillus delbrueckii subsp. bulgaricus
- Clostridium botulinum
- Escherichia coli Nissle 1917
- Shigella sonnei
- Bacillus infantis
- Salmonella enterica subsp. enterica serovar Dublin
- Ligilactobacillus salivarius UCC118
- Saccharomyces cerevisiae
- Litchi chinensis
- Saccharomyces boulardii nom. inval.
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Sus scrofa
- Homo sapiens
- Gallus gallus
- human metagenome
organisms_ner:
- Mus musculus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC2947383
filename: nihms233283f3.jpg
figlink: /pmc/articles/PMC2947383/figure/F3/
number: F3
caption: 'NF-κB activation involves several steps, including: 1) Phosphorylation of
  the inhibitor IκB molecule; 2) Ubiquitination of the inhibitor IκB molecule, which
  targets it for degradation (L. reuteri acts here); 3) Degradation of the inhibitor
  IκB molecule by the proteasome (VSL#3 acts here); 4) Translocation of NF-κB to the
  nucleus, now in active form; 5) Binding of NF-κB to pro-inflammatory gene targets
  in the nucleus; 6) Production of the gene products of inflammatory gene targets
  (e.g., MCP-1, IL-8) (E. coli Nissle, L. reuteri act here)'
papertitle: 'Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic
  Science.'
reftext: Elaine O. Petrof. Antiinflamm Antiallergy Agents Med Chem. ;8(3):260-269.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8802618
figid_alias: PMC2947383__F3
figtype: Figure
redirect_from: /figures/PMC2947383__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2947383__nihms233283f3.html
  '@type': Dataset
  description: 'NF-κB activation involves several steps, including: 1) Phosphorylation
    of the inhibitor IκB molecule; 2) Ubiquitination of the inhibitor IκB molecule,
    which targets it for degradation (L. reuteri acts here); 3) Degradation of the
    inhibitor IκB molecule by the proteasome (VSL#3 acts here); 4) Translocation of
    NF-κB to the nucleus, now in active form; 5) Binding of NF-κB to pro-inflammatory
    gene targets in the nucleus; 6) Production of the gene products of inflammatory
    gene targets (e.g., MCP-1, IL-8) (E. coli Nissle, L. reuteri act here)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ik
  - Nfkb1
  - Mcpt1
  - Ccl2
  - Nfkbib
  - Cxcl15
  - ik
  - pak2a
  - itpka
  - cxcl8a
  - tmub2
  - nedd8
  - cact
  - Dif
  - dl
  - Rel
  - CG11700
---
